» Articles » PMID: 35573255

Affinity Sedimentation and Magnetic Separation With Plant-Made Immunosorbent Nanoparticles for Therapeutic Protein Purification

Overview
Date 2022 May 16
PMID 35573255
Authors
Affiliations
Soon will be listed here.
Abstract

The virus-based immunosorbent nanoparticle is a nascent technology being developed to serve as a simple and efficacious agent in biosensing and therapeutic antibody purification. There has been particular emphasis on the use of plant virions as immunosorbent nanoparticle chassis for their diverse morphologies and accessible, high yield manufacturing plant cultivation. To date, studies in this area have focused on proof-of-concept immunosorbent functionality in biosensing and purification contexts. Here we consolidate a previously reported pro-vector system into a single vector to investigate and expand the utility of virus-based immunosorbent nanoparticle technology for therapeutic protein purification. We demonstrate the use of this technology for Fc-fusion protein purification, characterize key nanomaterial properties including binding capacity, stability, reusability, and particle integrity, and present an optimized processing scheme with reduced complexity and increased purity. Furthermore, we present a coupling of virus-based immunosorbent nanoparticles with magnetic particles as a strategy to overcome limitations of the immunosorbent nanoparticle sedimentation-based affinity capture methodology. We report magnetic separation results which exceed the binding capacity reported for current industry standards by an order of magnitude.

Citing Articles

Getting Hold of the Tobamovirus Particle-Why and How? Purification Routes over Time and a New Customizable Approach.

Wendlandt T, Britz B, Kleinow T, Hipp K, Eber F, Wege C Viruses. 2024; 16(6).

PMID: 38932176 PMC: 11209083. DOI: 10.3390/v16060884.


Facile Purification and Use of Tobamoviral Nanocarriers for Antibody-Mediated Display of a Two-Enzyme System.

Wendlandt T, Koch C, Britz B, Liedek A, Schmidt N, Werner S Viruses. 2023; 15(9).

PMID: 37766357 PMC: 10536799. DOI: 10.3390/v15091951.


Functionalizing silica sol-gel with entrapped plant virus-based immunosorbent nanoparticles.

McNulty M, Hamada N, Delzio J, McKee L, Nandi S, Longo M J Nanobiotechnology. 2022; 20(1):105.

PMID: 35246160 PMC: 8895542. DOI: 10.1186/s12951-022-01303-1.

References
1.
Frejd F, Kim K . Affibody molecules as engineered protein drugs. Exp Mol Med. 2017; 49(3):e306. PMC: 5382565. DOI: 10.1038/emm.2017.35. View

2.
Huang X, Stein B, Cheng H, Malyutin A, Tsvetkova I, Baxter D . Magnetic virus-like nanoparticles in N. benthamiana plants: a new paradigm for environmental and agronomic biotechnological research. ACS Nano. 2011; 5(5):4037-45. PMC: 3101318. DOI: 10.1021/nn200629g. View

3.
Xiong Y, Karuppanan K, Bernardi A, Li Q, Kommineni V, Dandekar A . Effects of N-Glycosylation on the Structure, Function, and Stability of a Plant-Made Fc-Fusion Anthrax Decoy Protein. Front Plant Sci. 2019; 10:768. PMC: 6611495. DOI: 10.3389/fpls.2019.00768. View

4.
Koch C, Wabbel K, Eber F, Krolla-Sidenstein P, Azucena C, Gliemann H . Modified TMV Particles as Beneficial Scaffolds to Present Sensor Enzymes. Front Plant Sci. 2016; 6:1137. PMC: 4689848. DOI: 10.3389/fpls.2015.01137. View

5.
Uhde-Holzem K, McBurney M, Tiu B, Advincula R, Fischer R, Commandeur U . Production of Immunoabsorbent Nanoparticles by Displaying Single-Domain Protein A on Potato Virus X. Macromol Biosci. 2015; 16(2):231-41. DOI: 10.1002/mabi.201500280. View